Fawzy, Ashraf http://orcid.org/0000-0002-6089-366X
Anderson, Julie A.
Cowans, Nicholas J.
Crim, Courtney
Wise, Robert
Yates, Julie C.
Hansel, Nadia N.
Funding for this research was provided by:
NIH NIEHS (F32ES028576 (AF))
GlaxoSmithKline plc (SUMMIT; HZC113782/NCT01313676)
Article History
Received: 31 January 2019
Accepted: 25 April 2019
First Online: 8 May 2019
Ethics approval and consent to participate
: The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.
: Not applicable.
: AF declares no conflict of interest. JAA, CC and JCY are employees of, and own shares in, GlaxoSmithKline plc. NJC is employed by Veramed Ltd., a Contract Research Organisation undertaking contracted statistical analyses of respiratory studies funded by GlaxoSmithKline plc. RW served as the Chair of the Summit Clinical Endpoint Committee and has received grant support and received consulting fees from GlaxoSmithKline plc during the conduct of the study. He has received grants and consulting fees from AstraZeneca and Boehringer Ingelheim. He has received consulting fees from Contrafect, Pulmonx, Roche, Spiration, Sunovion, Merck, Circassia, Verona, Mylan, Theravance, and Propeller Health unrelated to the submitted work. NNH has participated on advisory boards for GlaxoSmithKline plc, Mylan and AstraZeneca, and has received Research Grants from GlaxoSmithKline plc, AstraZeneca and Boehringer Ingelheim.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.